Our clinical trials Clinical trials Dose-Escalation and Expansion Study of BGB-16673 (B-Cell Malignancies - RECRUITMENT: OPEN) Project Title A Phase 1 Dose-Escalation and Expansion Study of BGB-16673 in Patients With B-Cell Malignancies Official Title A Phase 1, Open-Label, Dose-Escalation and -Expansion Study of the Bruton Tyrosine Kinase-Targeted Protein-Degrader BGB-16673 in Patients With B-Cell Malignancies Project Summary Study consists of two parts to explore BGB-16673 recommended dosing, a part 1 monotherapy dose finding and a part 2 (cohort expansion in two cohorts) Blood Disorders Marginal Zone Lymphoma Follicular Lymphoma Mantle Cell Lymphoma Chronic Lymphocytic Leukaemia Small Lymphocytic Leukaemia Waldenstrom's Macroglobulinemia Patient Recruitment Details Patient recruitment status: Open Number of Patients (Globally) Undetermined.